Variables | RFS | Â | OS | Â |
---|---|---|---|---|
 | HR (95% CI) | P-value | HR (95% CI) | P-value |
Sex | ||||
 Female | 1 |  | 1 |  |
 Male | 1.265 (1.003–1.594) | 0.047 | 1.352(1.085–1.683) | 0.007 |
Age | ||||
 < 50 year-old | 1 |  | 1 |  |
 50–65 year-old | 0.865 (0.625–1.196) | 0.380 | 0.881(0.607–1.278) | 0.504 |
 65–80 year-old | 0.825 (0.589–1.156) | 0.264 | 1.649(1.162–2.341) | 0.005 |
 ≥80 year-old | 0.809 (0.482–1.359) | 0.424 | 2.191(1.424–3.370) | < 0.001 |
CEA, pre-operation | ||||
 ≥5 ng/mL | 1 |  | 1 |  |
 < 5 ng/mL | 0.504 (0.400–0.634) | < 0.001 | 0.502(0.404–0.624) | <  0.001 |
NLR, pre-operation | ||||
 ≥ 2.87 | 1 |  | 1 |  |
 <  2.87 | 0.906 (0.710–1.156) | 0.425 | 0.697(0.558–0.870) | 0.001 |
Histology type | ||||
 Adenocarcinoma | 1 |  | 1 |  |
 Signet ring cell | 0.918 (0.316–2.668) | 0.876 | 1.213(0.429–3.426) | 0.716 |
 Mucinous | 0.965 (0.575–1.620) | 0.894 | 0.918(0.554–1.522) | 0.740 |
Histology grade | ||||
 Poorly | 1 |  | 1 |  |
 Moderate | 0.658(0.422–1.026) | 0.065 | 0.625(0.397–0.986) | 0.044 |
 Well | 0.539(0.280–1.035) | 0.063 | 0.647(0.354–1.183) | 0.157 |
NLN | ||||
 <  12 | 1 |  | 1 |  |
 ≥ 12 | 0.705 (0.549–0.906) | 0.006 | 0.655(0.522–0.823) | < 0.001 |
Stage III | ||||
 IIIA | 1 |  | 1 |  |
 IIIB | 2.494 (1.339–4.642) | 0.004 | 1.679 (1.049–2.686) | 0.031 |
 IIIC | 4.414(2.318–8.408) | < 0.001 | 2.482 (1.495–4.122) | < 0.001 |
Adjuvant C/T | ||||
 No | 1 |  | 1 |  |
 Yes | 1.054 (0.750–1.482) | 0.760 | 0.524(0.404–0.681) | < 0.001 |